inc headquart danver
lead provid medic devic design use
primarili use either cardiac catheter
lab cath lab intervent cardiologist
heart surgeri suit cardiovascular surgeon
patient receiv devic need
prophylact hemodynam support high-risk
angioplasti procedur experienc pre-shock
shock profound cardiogen shock
reason report
price chang estim chang analysi
maintain o/v invest rate reduc
former price target per share
compani uncharacterist slowdown fiscal
oper period brought long-term growth prospect
question street end remain opinion
mean like return
normal rate organ growth enter accordingli
compani share like remain range-bound throughout
better part pend demonstr oper execut
base compani virtual monopoli posit within expand
global top-tier margin profil strong debt-fre balanc sheet
materi reduc valuat assum long-term focu
maintain o/v invest rate share
lower price lower former
price target per share revis price
target impli revenu multipl approxim
guidanc updat lower revenu earn
estim compani specif lower
former million revenu estim million
increas earn estim per share likewis
revis former revenu earn estim
billion billion per share
guidanc updat reduc revenu oper
margin guidanc follow two quarter disappoint oper
result specif lower revenu guidanc
former rang million million revis rang
million million pre-cal consensu million
impli annual revenu growth likewis
compani moder oper margin guidanc former rang
revis rang pre-cal
valuat summari current trade
revenu non-gaap earn versu compar
industri peer trade like multipl respect
compani continu valu rel premium
despit consecut oper shortfal still view premium
warrant due factor previous cite invest
conclus section
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
fiscal summari review abmd fiscal total revenu increas year year million
pre-cal consensu million impella product revenu increas million intern
impella product revenu increas million quarterli gross margin declin year
year result smartassist launch unfavor geograph mix total oper expens increas
year year research develop expens increas sell gener administr expens
increas yield million oper incom result report oper margin
quarter earn per share includ abmd unreal gain
invest shockwav medic rate excess tax benefit relat stock compens
exclud state one-tim item report adjust earn per share oper
fiscal period fiscal oper period report domest patient volum
growth result correspond impella product revenu million impella util slightli
favor emerg indic versu protect pci quarter furthermor open
new site fewer histor norm compani priorit util physician train exist
site result domest hospit impella cp penetr impella
penetr impella penetr impella rp penetr
lastli fiscal oper period domest reorder rate slightli exceed averag
combin inventori held hospit impella cp unit consist fiscal level
take action order reinvigor domest impella growth undertak multi-prong approach
restor sustain top-tier organ growth first compani adjust domest strategi distribut
model expand number sale region increas territori account manag order enabl
extend compani reach commun hospit network also go deeper within exist site
addit expand clinic educ effort notabl relat vascular access closur
also launch smartassist platform facilit eas use combin initi design facilit
increas util across compani instal base current patient refer via
site impli signific untap growth opportun within exist institut end estim
assum exist total site increas util impella cp per month would stand realiz
addit million per annum increment revenu
market satur recent top-lin weak prompt question end market reach
satur state differ patient popul realli big previous thought start unit state
alon approxim individu class ii iv heart failur coronari arteri diseas
low eject fraction mani also high risk acut kidney injuri aki could potenti benefit
impella util within popul segment current target patient high-risk pci
also addit patient ischemia remain undiagnos year addit
assum shock patient estim still receiv treatment iabp
anoth receiv ionotrop simpli put continu see long runway growth view
reach satur within either potenti domest market opportun conserv
balanc sheet review oper period gener million oper cash flow result
compani exit fiscal quarter million cash cash equival debt equival
net cash per dilut share addit conjunct earn releas compani announc
known unknown recal april center medicar medicaid servic publish propos
ipp specif propos increas drg increas
drg reduct drg code
impella rp so-cal hub spoke referr reimburs would increas third consecut year
reimburs drg would scrutini recal initi reimburs propos
approxim ultim result final chang relat devic sale increas
respect volatil around ms-drg remain troubl opinion relat
reimburs although like undergo cut ultim see favor revis follow year
data avail howev uncertainti relat known unknown creat near-term overhang
share publish final rule event expect occur next sever week
thousand except per share data
product revenu
research develop
sell gener administr
compani report stephen inc estim
increas cog due launch smartassist
geograph mix
earn includ unreal
gain invest shockwav
excess tax benefit relat stock compens
compani document stephen inc estim
stephen inc estim
consolid statement incom
dollar thousand except per share data
product revenu
research develop
sell gener administr
total incom expens
fiscal period
fiscal period
incom continu oper tax
tax incom continu oper
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
